Profund Advisors’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-11,555
Closed -$271K 1197
2022
Q1
$271K Buy
11,555
+2,247
+24% +$55K 0.01% 1014
2021
Q4
$253K Buy
9,308
+706
+8% +$18.9K 0.01% 1103
2021
Q3
$245K Sell
8,602
-1,934
-18% -$58.9K 0.01% 1111
2021
Q2
$318K Buy
10,536
+604
+6% +$17.8K 0.01% 1009
2021
Q1
$253K Buy
9,932
+1,196
+14% +$30.6K 0.01% 1113
2020
Q4
$214K Buy
+8,736
New +$164K 0.01% 1066
2019
Q2
Sell
-9,329
Closed -$253K 1226
2019
Q1
$253K Buy
9,329
+2,242
+32% +$75.2K 0.01% 1023
2018
Q4
$234K Sell
7,087
-3,339
-32% -$134K 0.01% 940
2018
Q3
$486K Buy
10,426
+310
+3% +$14.2K 0.02% 842
2018
Q2
$438K Sell
10,116
-916
-8% -$43.9K 0.02% 878
2018
Q1
$614K Sell
11,032
-80
-0.7% -$4.38K 0.02% 676
2017
Q4
$594K Sell
11,112
-1,308
-11% -$61.7K 0.02% 704
2017
Q3
$536K Buy
12,420
+816
+7% +$38.8K 0.02% 725
2017
Q2
$701K Sell
11,604
-3,954
-25% -$234K 0.03% 535
2017
Q1
$1.08M Sell
15,558
-232
-1% -$16.1K 0.05% 400
2016
Q4
$1.05M Buy
15,790
+1,809
+13% +$118K 0.05% 400
2016
Q3
$926K Buy
13,981
+1,511
+12% +$103K 0.04% 420
2016
Q2
$903K Buy
12,470
+35
+0.3% +$2.41K 0.04% 437
2016
Q1
$804K Sell
12,435
-4,539
-27% -$301K 0.04% 451
2015
Q4
$1.22M Buy
16,974
+4,387
+35% +$324K 0.06% 295
2015
Q3
$967K Sell
12,587
-5,426
-30% -$438K 0.06% 294
2015
Q2
$1.33M Sell
18,013
-3,005
-14% -$216K 0.06% 288
2015
Q1
$1.52M Buy
21,018
+3,601
+21% +$250K 0.06% 294
2014
Q4
$1.15M Buy
17,417
+3,930
+29% +$240K 0.05% 379
2014
Q3
$739K Sell
13,487
-4,351
-24% -$247K 0.03% 510
2014
Q2
$1.04M Sell
17,838
-2,569
-13% -$151K 0.05% 458
2014
Q1
$1.26M Buy
20,407
+336
+2% +$19.5K 0.06% 350
2013
Q4
$1.07M Buy
20,071
+791
+4% +$42.5K 0.05% 473
2013
Q3
$968K Buy
19,280
+5,554
+40% +$271K 0.05% 455
2013
Q2
$629K Buy
+13,726
New +$614K 0.04% 495

Other funds holding MD

Profund Advisors's MD Position: Q2 2022 in Review

Profund Advisors sold out of Pediatrix Medical (MD) in Q2 2022, closing a stake of 11,555 shares — an estimated $271K sold.

Profund Advisors first reported a position in MD in Q2 2013 and held it in 30 quarters. The position peaked at $1.52M in Q1 2015. 198 funds tracked by Wall St. Rank hold MD as of Q2 2022.

  • Profund Advisors reported no remaining Pediatrix Medical position as of Q2 2022 after selling out during the quarter.
  • Profund Advisors sold 11,555 Pediatrix Medical shares in Q2 2022, an estimated $271K.
  • Profund Advisors first reported a position in Pediatrix Medical in Q2 2013 and held it in 30 quarters.
  • Profund Advisors's Pediatrix Medical position peaked at $1.52M in Q1 2015.
  • 198 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2022.

Based on Profund Advisors's 13F filing for Q2 2022, filed 1 Aug 2022.